Theranexus (EPA:ALTHX)

PRESS RELEASE

published on 12/17/2024 at 18:00, 1 year 1 month ago

THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE LICENSING AGREEMENT TO COMMERCIALIZE THERANEXUS TX01 FOR TWO RARE NEUROLOGICAL DISORDERS
Theranexus and Exeltis sign license agreement for TX01, expanding treatment for rare neurological diseases. Exeltis to market TX01 across Europe and other regions

License Agreement Theranexus Neurological Diseases Exeltis TX01
BRIEF

published on 11/19/2024 at 18:05, 1 year 2 months ago

Theranexus presents positive results for the treatment of Batten disease CLN3

Clinical Trial Theranexus Batten-1 Batten Disease Visual Acuity
PRESS RELEASE

published on 11/19/2024 at 18:00, 1 year 2 months ago

Update on the Theranexus' Batten-1 project in CLN3 Batten's disease
Theranexus and BBDF present positive results of Batten-1 trial in CLN3 Batten disease patients, showing safety and efficacy of miglustat. Expanded use indicates potential in visual acuity stabilization

Theranexus BBDF Batten-1 Trial CLN3 Batten Disease Miglustat
BRIEF

published on 10/23/2024 at 18:05, 1 year 3 months ago

Theranexus Announces Its Cash Position as of September 30, 2024

Treasury Batten Disease Miglustat Research Tax Credit Industrial Partnerships
PRESS RELEASE

published on 10/23/2024 at 18:00, 1 year 3 months ago

THERANEXUS ANNOUNCES ITS CASH POSITION AS OF SEPTEMBER 30, 2024
Theranexus reports €1.9 million cash position as of September 30, 2024, with plans for product registrations and phase 3 trials in rare neurological diseases

Cash Position Biopharmaceutical Theranexus Rare Neurological Diseases Product Registrations
BRIEF

published on 10/17/2024 at 18:05, 1 year 3 months ago

Theranexus partners with Synerlab for a breakthrough in the treatment of Niemann-Pick C

Theranexus EMA Synerlab Miglustat Niemann-Pick C
PRESS RELEASE

published on 10/17/2024 at 18:00, 1 year 3 months ago

THERANEXUS JOINS UP WITH SYNERLAB TO PREPARE THE COMMERCIALIZATION OF ITS PEDIATRIC FORMULATION IN NIEMANN-PICK TYPE C DISEASE
Theranexus partners with Synerlab to produce oral solution of miglustat for Niemann-Pick type C disease, aiming for EMA approval and commercialization by 2026. Novel pediatric formulation Mig-OS provides new therapeutic option for NPC patients

Theranexus Synerlab Miglustat Niemann-Pick Type C Disease EMA Approval
BRIEF

published on 09/26/2024 at 18:05, 1 year 4 months ago

Theranexus announces its financial results for the first half of 2024

Financial Results Cost Reduction Biopharmaceutical Theranexus Batten-1
PRESS RELEASE

published on 09/26/2024 at 18:00, 1 year 4 months ago

THERANEXUS ANNOUNCES FIRST HALF 2024 FINANCIAL RESULTS
Theranexus reports cost reduction success and positive first half 2024 financial results, led by completion of Batten-1 clinical trial and operating grants

Financial Results Cost Reduction Clinical Trial Theranexus Batten-1
BRIEF

published on 07/11/2024 at 18:50, 1 year 6 months ago

Theranexus announces its cash flow as of June 30, 2024 and details the progress of Batten-1

Treasury Funding Theranexus Batten-1 Neurological Disease

Published on 02/02/2026 at 00:05, 1 hour 55 minutes ago

Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 1 day 22 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 23 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 2 days ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 2 days 2 hours ago

BE Resources Announces Private Placement

View all ACCESSWIRE

Published on 02/01/2026 at 20:25, 5 hours 35 minutes ago

WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 10 hours ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 13 hours ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 23 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 2 days 4 hours ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call

View all EQS

Published on 01/30/2026 at 17:45, 2 days 8 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 2 days 18 hours ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 3 days 8 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 3 days 8 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 3 days 8 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News